Literature DB >> 11160023

DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge.

J P Sauzet1, B L Perlaza, K Brahimi, P Daubersies, P Druilhe.   

Abstract

DNA-based immunization of mice by Plasmodium falciparum liver-stage antigen 3 (PfLSA3), a novel highly conserved P. falciparum preerythrocytic antigen, was evaluated. Animals developed a dominant Th1 immune response (high gamma interferon T-cell responses and predominance of immunoglobulin G2a) to each of three recombinant proteins spanning the molecule. We have exploited the immunological cross-reactivity of PfLSA3 with its putative homologue on sporozoites of the rodent parasite Plasmodium yoelii, and we show for the first time that responses induced by PfLSA3 in mice significantly protect against a heterologous challenge by P. yoelii sporozoites. These results support a significant effect of DNA-induced immune responses on preerythrocytic stages.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160023      PMCID: PMC98007          DOI: 10.1128/IAI.69.2.1202-1206.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new Plasmodium falciparum pre-erythrocytic molecules.

Authors:  L Benmohamed; A Thomas; M Bossus; K Brahimi; J Wubben; H Gras-Masse; P Druilhe
Journal:  Vaccine       Date:  2000-06-15       Impact factor: 3.641

Review 2.  DNA vaccines.

Authors:  W C Lai; M Bennett
Journal:  Crit Rev Immunol       Date:  1998       Impact factor: 2.214

3.  Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite.

Authors:  Y Kang; P A Calvo; T M Daly; C A Long
Journal:  J Immunol       Date:  1998-10-15       Impact factor: 5.422

4.  Immunogenicity of four Plasmodium falciparum preerythrocytic antigens in Aotus lemurinus monkeys.

Authors:  B L Perlaza; M Arévalo-Herrera; K Brahimi; G Quintero; J C Palomino; H Gras-Masse; A Tartar; P Druilhe; S Herrera
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

5.  Recombinant human gamma interferon inhibits simian malaria.

Authors:  R K Maheshwari; C W Czarniecki; G P Dutta; S K Puri; B N Dhawan; R M Friedman
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

6.  Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.

Authors:  L BenMohamed; H Gras-Masse; A Tartar; P Daubersies; K Brahimi; M Bossus; A Thomas; P Druilhe
Journal:  Eur J Immunol       Date:  1997-05       Impact factor: 5.532

7.  Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon.

Authors:  A Ferreira; L Schofield; V Enea; H Schellekens; P van der Meide; W E Collins; R S Nussenzweig; V Nussenzweig
Journal:  Science       Date:  1986-05-16       Impact factor: 47.728

8.  Interleukin 12 induction of interferon gamma-dependent protection against malaria.

Authors:  M Sedegah; F Finkelman; S L Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

9.  Sterile protection of monkeys against malaria after administration of interleukin-12.

Authors:  S L Hoffman; J M Crutcher; S K Puri; A A Ansari; F Villinger; E D Franke; P P Singh; F Finkelman; M K Gately; G P Dutta; M Sedegah
Journal:  Nat Med       Date:  1997-01       Impact factor: 53.440

10.  Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3.

Authors:  P Daubersies; A W Thomas; P Millet; K Brahimi; J A Langermans; B Ollomo; L BenMohamed; B Slierendregt; W Eling; A Van Belkum; G Dubreuil; J F Meis; C Guérin-Marchand; S Cayphas; J Cohen; H Gras-Masse; P Druilhe; L B Mohamed
Journal:  Nat Med       Date:  2000-11       Impact factor: 53.440

View more
  18 in total

1.  Usefulness of the recombinant liver stage antigen-3 for an early serodiagnosis of Plasmodium falciparum infection.

Authors:  Hyeong-Woo Lee; Sung-Ung Moon; Hye-Sun Ryu; Yeon-Joo Kim; Shin-Hyeong Cho; Gyung-Tae Chung; Khin Lin; Byoung-Kuk Na; Yoon Kong; Kyung-Suk Chung; Tong-Soo Kim
Journal:  Korean J Parasitol       Date:  2006-03       Impact factor: 1.341

2.  DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice.

Authors:  Preeti Pancholi; Marion Perkus; Nancy Tricoche; Qingyan Liu; Alfred M Prince
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 3.  Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: implications for vaccine design.

Authors:  Javier E Garcia; Alvaro Puentes; Manuel E Patarroyo
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

4.  Induction of strain-transcending immunity against Plasmodium chabaudi adami malaria with a multiepitope DNA vaccine.

Authors:  T Scorza; K Grubb; P Smooker; A Rainczuk; D Proll; T W Spithill
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

5.  O-GlcNAc modification of the anti-malarial vaccine candidate PfAMA1: in silico-defined structural changes and potential to generate a better vaccine.

Authors:  Nasir Uddin; Daniel C Hoessli; Asma Butt; Afshan Kaleem; Zeeshan Iqbal; Imran Afzal; Zahra Zamani; Abdul Rauf Shakoori
Journal:  Mol Biol Rep       Date:  2011-10-22       Impact factor: 2.316

6.  Long-term multiepitopic cytotoxic-T-lymphocyte responses induced in chimpanzees by combinations of Plasmodium falciparum liver-stage peptides and lipopeptides.

Authors:  Lbachir BenMohamed; Alan Thomas; Pierre Druilhe
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

7.  A baculovirus dual expression system-based malaria vaccine induces strong protection against Plasmodium berghei sporozoite challenge in mice.

Authors:  Shigeto Yoshida; Masanori Kawasaki; Norimitsu Hariguchi; Kuniko Hirota; Makoto Matsumoto
Journal:  Infect Immun       Date:  2009-02-17       Impact factor: 3.441

8.  Evidence for multiple B- and T-cell epitopes in Plasmodium falciparum liver-stage antigen 3.

Authors:  Aissatou Toure-Balde; Blanca-Liliana Perlaza; Jean-Pierre Sauzet; Mouhamadou Ndiaye; Georgette Aribot; Adama Tall; Cheikh Sokhna; Christophe Rogier; Giampietro Corradin; Christian Roussilhon; Pierre Druilhe
Journal:  Infect Immun       Date:  2009-01-12       Impact factor: 3.441

9.  Liver stage antigen 3 Plasmodium falciparum peptides specifically interacting with HepG2 cells.

Authors:  Javier E García; Hernando Curtidor; Ramses López; Luis Rodríguez; Ricardo Vera; John Valbuena; Jaiver Rosas; Marisol Ocampo; Alvaro Puentes; Martha Forero; Manuel A Patarroyo; Manuel Elkin Patarroyo
Journal:  J Mol Med (Berl)       Date:  2004-08-07       Impact factor: 4.599

10.  Optimising Controlled Human Malaria Infection Studies Using Cryopreserved P. falciparum Parasites Administered by Needle and Syringe.

Authors:  Susanne H Sheehy; Alexandra J Spencer; Alexander D Douglas; B Kim Lee Sim; Rhea J Longley; Nick J Edwards; Ian D Poulton; Domtila Kimani; Andrew R Williams; Nicholas A Anagnostou; Rachel Roberts; Simon Kerridge; Merryn Voysey; Eric R James; Peter F Billingsley; Anusha Gunasekera; Alison M Lawrie; Stephen L Hoffman; Adrian V S Hill
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.